Germany, the Netherlands and Belgium call for efforts at European level to develop a vaccine against bluetongue serotype 3

Published Oct 24, 2023

Tridge summary

Bluetongue disease, specifically serotype 3, has been confirmed in Germany for the first time. The disease has rapidly spread across thousands of farms in Germany, the Netherlands, and Belgium. The agriculture ministers of these countries are calling for efforts to find a vaccine against serotype 3 and are urging pharmaceutical companies to work on developing one.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Recently, the national reference laboratory for bluetongue disease in Germany confirmed the first infection with serotype 3 of the disease in the country on a sheep farm in the district of Kleve, North Rhine-Westphalia. This outbreak was added to those detected in the Netherlands at the beginning of September in the provinces of North Holland and Utrecht, after which it has spread rapidly. To date, they have been identified on thousands of farms, the majority on sheep farms. The disease has also been detected in Belgium. This marks the first appearance of bluetongue serotype 3 in the region. And in Europe until now it had only been discovered in southern Italy. Other countries with the disease include Tunisia, Israel and much of southern Africa. This serotype is not present in Spain, for which there is no vaccine, and cases of serotypes 1, 4 and 8 have been detected. Faced with this situation, the Ministers of Agriculture of Germany, the Netherlands and Belgium, Cem Özdemir, Piet ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.